WooGene B&G Co., Ltd (KOSDAQ:018620)
South Korea · Delayed Price · Currency is KRW 867.00
-4.00 (-0.46%)
Last updated: Oct 28, 2025, 9:00 AM KST
WooGene B&G Company Description
WooGene B&G Co., Ltd. engages veterinary medicines, microbial technology, and vaccines business in South Korea and internationally.
It offers antibiotic, vaccine, nutrient, anti-inflammation, metabolic stimulant, and iron supplement products for swine, poultry, cattle, aquatic animals, companion animals, and raw materials, as well as operates vaccine research center.
The company was formerly known as WooJin Co., Ltd. and changed its name to WooGene B&G Co., Ltd. in March 2001.
WooGene B&G Co., Ltd. was founded in 1977 and is headquartered in Hwaseong-si, South Korea.
WooGene B&G Co., Ltd
| Country | South Korea |
| Founded | 1977 |
| Industry | Pharmaceutical Preparations |
| Employees | 80 |
| CEO | Seokjin Kang |
Contact Details
Address: 230, Jeongmunsongsan-ro Hwaseong-si South Korea | |
| Phone | 82 3 1352 0185 |
| Website | woogenebng.com |
Stock Details
| Ticker Symbol | 018620 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Seokjin Kang | Chief Executive Officer |